prsync

Herpes Zoster (Shingles) Pipeline Therapeutics Market Review H1 2017

Press Release   •   Jun 12, 2017 19:46 IST

Pharmaceutical and Healthcare Herpes Zoster (Shingles) Pipeline Review H1 2017 provides comprehensive information on the therapeutics under development for Herpes Zoster (Shingles) (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

For Complete PDF Report Inquire At http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=983988

Herpes Zoster (Shingles) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Herpes Zoster (Shingles) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Unknown stages are 2, 3, 1, 1, 6 and 1 respectively.

Companies Involved in Herpes Zoster (Shingles) Therapeutics Development Discussed - Astellas Pharma Inc, Beijing Minhai Biotechnology Co Ltd, ContraVir Pharmaceuticals Inc, Epiphany Biosciences Inc, Foamix Pharmaceuticals Ltd, GeneOne Life Science Inc, GlaxoSmithKline Plc, Merck & Co Inc, NAL Pharmaceuticals Ltd, NanoViricides Inc, SK Chemicals Co Ltd, TSRL Inc, XBiotech Inc.

Get Discount on Complete 63 Pages with 22 Tables and 10 Figures at http://www.reportsnreports.com/contacts/discount.aspx?name=983988 .

Drug Profile for Herpes Zoster (Shingles) Discussed - acyclovir, amenamevir, FV-100, GLS-5100, GSK-1437173A, herpes zoster vaccine, Monoclonal Antibody for Shingles, NAL-3223, NBP-608, NN-001, Small Molecule for Shingles, TSR-087, V-212, valomaciclovir stearate.

Herpes Zoster (Shingles) (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.The pipeline guide provides a snapshot of the global therapeutic landscape of Herpes Zoster (Shingles) (Infectious Disease). The pipeline guide reviews pipeline therapeutics for Herpes Zoster (Shingles) (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources. The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

Direct Purchase This Report at http://www.reportsnreports.com/purchase.aspx?name=983988 .

The pipeline guide features descriptive drug profiles for the pipeline products which comprise product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. The pipeline guide reviews key companies involved in Herpes Zoster (Shingles) (Infectious Disease) therapeutics and enlists all their major and minor projects. The pipeline guide evaluates Herpes Zoster (Shingles) (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. The pipeline guide encapsulates all the dormant and discontinued pipeline projects. The pipeline guide reviews latest news related to pipeline therapeutics for Herpes Zoster (Shingles) (Infectious Disease)

List of Tables:

  • Number of Products under Development for Herpes Zoster (Shingles), H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Products under Development by Companies, H1 2017
  • Number of Products by Stage and Target, H1 2017
  • Number of Products by Stage and Mechanism of Action, H1 2017
  • Number of Products by Stage and Route of Administration, H1 2017
  • Number of Products by Stage and Molecule Type, H1 2017
  • Herpes Zoster (Shingles) - Pipeline by Astellas Pharma Inc, H1 2017
  • Herpes Zoster (Shingles) - Pipeline by Beijing Minhai Biotechnology Co Ltd, H1 2017
  • Herpes Zoster (Shingles) - Pipeline by ContraVir Pharmaceuticals Inc, H1 2017
  • Herpes Zoster (Shingles) - Pipeline by Epiphany Biosciences Inc, H1 2017
  • Herpes Zoster (Shingles) - Pipeline by Foamix Pharmaceuticals Ltd, H1 2017
  • Herpes Zoster (Shingles) - Pipeline by GeneOne Life Science Inc, H1 2017
  • Herpes Zoster (Shingles) - Pipeline by GlaxoSmithKline Plc, H1 2017
  • Herpes Zoster (Shingles) - Pipeline by Merck & Co Inc, H1 2017
  • Herpes Zoster (Shingles) - Pipeline by NAL Pharmaceuticals Ltd, H1 2017
  • Herpes Zoster (Shingles) - Pipeline by NanoViricides Inc, H1 2017
  • Herpes Zoster (Shingles) - Pipeline by SK Chemicals Co Ltd, H1 2017
  • Herpes Zoster (Shingles) - Pipeline by TSRL Inc, H1 2017
  • Herpes Zoster (Shingles) - Pipeline by XBiotech Inc, H1 2017
  • Herpes Zoster (Shingles) - Dormant Projects, H1 2017
  • Herpes Zoster (Shingles) - Discontinued Products, H1 2017 7

Contact Us:

Ritesh Tiwari

2nd Floor, Metropole,

Bund Garden Road,

Pune – 411001,

India.

Tel: + 1 888 391 5441

E-mail: sales@ reportsnreports.com

ReportsnReports.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.